Journal of the British Society of Special Care Dentistry
April 2026
Volume: 26
Issue: 2
DOI: 10.63507/BJEA6767
Title: Using the environment as the first drug: a ‘sensory-first’ conscious sedation protocol for neurodivergent patients
Author: Mumtaz A
Abstract:
With adult diagnoses of autism spectrum disorder and attention deficit hyperactivity disorder rising, community dental services face increasing demand. Yet current intravenous conscious sedation protocols remain built around neurotypical pharmacodynamics and often fail this population. This paper challenges the assumption of a standardised sensory baseline, arguing instead for protocols to be adapted to accommodate patients with sensory gating deficits and physiological differences in receptor density, number and signalling. For these patients, the clinical environment itself triggers sympathetic excitation, leading to a ‘hostile baseline’ working against the sedative agents. Critically, this narrows the safety margin between anxiolysis and respiratory depression, while standard titration can risk a paradoxical reaction in ADHD patients due to disinhibition in regions of the brain that regulate emotional and behavioural control.
Therefore, this paper proposes a new ‘Sensory-First’ protocol for sedation. By moving beyond the mindset of a purely pharmacological approach to anxiolysis, it advocates for the management of the patient’s autonomic nervous system before any drugs are administered. The protocol proposes integrating ‘sensory passports’, high-frequency vibration devices for cannulation and deep pressure stimulation to help non-pharmacologically reduce sympathetic drive and physiologically prime the patient for successful sedation. Furthermore, it introduces ‘micro-titration’ to screen for paradoxical reactions. By treating the clinical environment as the ‘first drug’, this approach widens the therapeutic window, promotes predictability and ensures equitable access to care in compliance with the Equality Act 2010. Effective sedation for neurodivergent adults ultimately requires clinicians to treat the patient’s sensory system before treating their receptors.
To access this article please click here.
Please note: members will need to log on to access the article.
If you have a query relating to this article please email:
Click here to return to the BSSCD Journal 26-2 index